Fentanyl has emerged as the primary cause of illicit drug deaths in Canada and the United States, and its trafficking has ...
A joint study conducted by UPM Raflatac and Corning Pharmaceutical Technologies has revealed the sustainability and performance benefits of their combined packaging solutions for the pharmaceutical ...
With a positive outlook, McKesson raised its fiscal 2025 adjusted EPS guidance to a range of $32.55 to $32.95, indicating confidence in its strategic initiatives. This new projection reflects an ...
NEW YORK - McKesson Corporation (NYSE:MCK) reported third-quarter earnings and revenue that fell short of analyst expectations, sending shares down 4.3% in after-hours trading. The pharmaceutical ...